Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

AUTOR(ES)

Lowe, S W

RESUMO

p53-deficient mouse embryonic fibroblasts were used to establish a direct mechanism of tumor suppression by p53 involving the destruction of oncogene-expressing cells by apoptosis. The absence of p53 enhanced cell growth, appeared sufficient for immortalization, and allowed a single oncogene [adenovirus early region 1A (E1A)] to transform cells to a tumorigenic state. p53 suppressed transformation of E1A-expressing cells by apoptosis. Apoptosis was associated with p53 stabilization and was triggered by environmental signals that normally suppress cell growth. Absence of even a single p53 allele significantly enhanced cell growth and survival. Although abrogation of apoptosis allowed transformation by E1A alone, escape from apoptosis susceptibility was not a prerequisite for tumor growth. Consequently, p53 mutation could enhance the survival of malignant cells expressing oncogenes activated early in tumor progression.

Documentos Relacionados

• Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase
• Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway
• Elevated mutagenesis and decreased DNA repair at a transgene are associated with proliferation but not apoptosis in p53-deficient cells
• Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice
• Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.